Altimmune, Inc. (ALT)

4.66 -0.03 (-0.64%) USD  |  NASDAQ  |  Feb 10, 16:00
4.69 +0.03 (+0.64%) Pre-Market: 08:22
More

Altimmune EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade